Top Losers

hhgregg, Inc. (NYSE: HGG) shares dipped 44.3 percent to $0.730. hhgregg reported preliminary Q3 revenue of $453 million. NanoString Technologies Inc (NASDAQ: NSTG) declined 20.7 percent to $18.24 after the company issued weak revenue forecast for FY2016. Egalet Corp (NASDAQ: EGLT) shares...

COPsync Inc (NASDAQ: COYN) shares tumbled 39.4 percent to $0.624 after the company reported a $1.15 million registered direct offering. Ruby Tuesday, Inc. (NYSE: RT) shares dropped 21.5 percent to $2.77 after the company posted a wider quarterly loss. Ruby Tuesday reported Q2 adjusted loss...

AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) shares dipped 26.7 percent to $2.67 after the company disclosed that Macrilen failed to achieve its objective in Phase 3 trial. The company is evaluating whether it will continue development of Macrilen. Kohl's Corporation (NYSE: KSS) dropped 18...

Agile Therapeutics Inc (NASDAQ: AGRX) shares dipped 48 percent to $2.60 after the company reported top-line results from its Phase 3 SECURE clinical trial of Twirla. The company plans to resubmit results later in the first half of 2017. Emergent Capital Inc (NYSE: EMG) shares dropped 34.2...

Inotek Pharmaceuticals Corp (NASDAQ: ITEK) shares tumbled 70.5 percent to $1.80 after the company disclosed that it did not achieve its primary endpoint in first Phase 3 trial of trabodenoson for glaucoma. Sito Mobile Ltd (NASDAQ: SITO) shares declined 26.8 percent to $2.70. SITO Mobile...

Innocoll Holdings PLC (NASDAQ: INNL) shares dropped 64.7 percent to $0.625 after the company disclosed that it has received a Refusal to File letter from the FDA related to XARACOLL New Drug Application. Opko Health Inc. (NASDAQ: OPK) shares dipped 18.9 percent to $9.30 after the company...

Cempra Inc (NASDAQ: CEMP) shares dipped 57.4 percent to $2.60 after the company disclosed that it has received a Complete Response Letter from the FDA stating that solithromycin NDAs cannot be approved until safety information and manufacturing facility deficiencies are resolved. Interpace...

Anthera Pharmaceuticals Inc (NASDAQ: ANTH) shares dropped 66 percent to $0.683 after the company disclosed that the Phase 3 SOLUTION study with Sollpura has missed the primary endpoint. VisionChina Media Inc (ADR) (NASDAQ: VISN) shares declined 12 percent to $4.99. VisionChina reported Q3...

Endologix, Inc. (NASDAQ: ELGX) shares tumbled 19 percent to $5.82 after the company reported a temporary hold on AFX® Endovascular AAA System to resolve a manufacturing issue. Basic Energy Services, Inc (NYSE: BAS) shares fell 17.6 percent to $32.14. On Friday, Basic Energy Services...

Bonanza Creek Energy Inc (NYSE: BCEI) shares tumbled 57.7 percent to $0.830 after the company reported that it has entered into a restructuring support agreement with bondholders holding more than $400 million in unsecured debt. The company also disclosed that it will commence its prepackaged...

OvaScience Inc (NASDAQ: OVAS) shares tumbled 50.4 percent to $1.47 after the company announced plans to reduce workforce by 30 percent and disclosed that its CEO Harald Stock is stepping down. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares dipped 21.8 percent to $2.13 after the company...

xG Technology Inc (NASDAQ: XGTI) shares dropped 54.4 percent to $1.65 after the company reported the pricing of its $10 million offering. Modsys International Ltd (NASDAQ: MDSY) shares tumbled 18 percent to $0.992. Modsys shares have dipped 40.64 percent over the past 52 weeks, while the S...

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) shares dropped 16.2 percent to $14.00 after the company reported a proposed convertible senior note offering. Flotek Industries Inc (NYSE: FTK) shares fell 13.6 percent to $9.06 after the company issued an interim update on Q4 operations. The...

JAKKS Pacific, Inc. (NASDAQ: JAKK) shares tumbled 30.5 percent to $4.90. Piper Jaffray downgraded Jakks Pacific from Overweight to Neutral, while BMO Capital downgraded Jakks Pacific to Market Perform. Voltari Corp (NASDAQ: VLTC) shares fell 20.4 percent to $2.15. Voltari shares have dropped...

Pacific Biosciences of California (NASDAQ: PACB) shares tumbled 40.4 percent to $4.11 after the company reported the termination of agreement with Roche Diagnostics around the company company's Single Molecule, Real-Time technology. Ocean Rig UDW Inc. (NASDAQ: ORIG) shares dipped 21.2...